Saladax Biomedical Inc

BETHLEHEM, PA · Medtech · Private

Therapeutic drug monitoring assays for psychiatric and oncology medications

Claim this profile

Follows are private to you and power your alerts

Updated · saladax.com

Sector
Medtech
Headquarters
BETHLEHEM, PA
Latest Form D
$22.9M, Sep 2013
Total capital
$30.9M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$30.9M
2 Form D · last Sep 2013
158 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
28 pending · first 2020
Rank in peer group#45 of 160

Capital timeline

20092010201120122013FEDERAL ↑EQUITY ↓Cumulative $30.9M1st Form D$7.9M2nd Form D$22.9M
20092010201120122013FEDERAL ↑EQUITY ↓Cumulative $30.9M1st Form D$7.9M2nd Form D$22.9M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$22.9M
  • Private capital raisedForm D · SEC · 1st filing$7.9M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#45 · top 28%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Adrienne ChomaExecutive Officer, DirectorNamed in SEC Form D filings
  • Edward L. EricksonDirectorNamed in SEC Form D filings
  • Enrico J. PetrilloDirectorNamed in SEC Form D filings
  • Greg L. CritchfieldDirectorNamed in SEC Form D filings
  • James J. HenselDirectorNamed in SEC Form D filings
  • Joel J. GrossDirectorNamed in SEC Form D filings
Show all 8 people
  • Kevin J. HarterExecutive Officer, DirectorNamed in SEC Form D filings
  • Salvatore J. SalamoneExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 30
  • PendingClozapine ImmunoassayUSPTOApplication 19638633
  • GrantedAntibodies To Paliperidone And Use ThereofUSPTOUS 11,385,246
  • PendingAntibodies To Risperidone Haptens And Use ThereofUSPTOApplication 16948230
Show all 30 patent records
  • Clozapine ImmunoassayAug 13, 2026 · Application 19638633Pending
  • Antibodies To Paliperidone And Use ThereofJul 12, 2022 · US 11,385,246Granted
  • Antibodies To Risperidone Haptens And Use ThereofDec 24, 2020 · Application 16948230Pending
  • Clozapine ImmunoassaySep 24, 2020 · Application 16899667Pending
  • Immunoassay Standards And Measurement Of Clinical Biomarkers Using Intra-assay Calibration StandardsJun 2, 2020 · US 10,670,612Granted
  • Antibodies To Quetiapine Haptens And Use ThereofFeb 6, 2020 · Application 16587443Pending
  • Antibodies To Quetiapine And Use ThereofSep 5, 2019 · Application 16410548Pending
  • Gemcitabine ImmunoassayApr 16, 2015 · Application 14576877Pending
  • Clozapine ImmunoassayOct 9, 2014 · Application 14284503Pending
  • Gemcitabine ImmunoassaySep 18, 2014 · Application 13835210Pending
  • Lenalidomide and Thalidomide ImmunoassaysJan 23, 2014 · Application 13852523Pending
  • Lenalidomide and Thalidomide ImmunoassaysAug 15, 2013 · Application 13852308Pending
  • Doxorubicin ImmunoassayApplication PCTUS2006011022Pending
  • Docetaxel ImmunoassayApplication PCTUS2006009957Pending
  • 5-FLUORO-URACIL ImmunoassayApplication PCTUS2006003674Pending
  • Enzymatic Measurement Of Imatinib MesylateApplication PCTUS2005041059Pending
  • Busulfan ImmunoassayApplication PCTUS2005032789Pending
  • Taxol ImmunoassayApplication PCTUS2005026748Pending
  • Cytoxan Antibodies And ImmunoassayApplication PCTUS2005025483Pending
  • Immunoassay Standards And Measurement Of Tau Using Intra-assay Calibration StandardsApplication PCTUS2013076046Pending
  • Immunoassay Standards And Measurement Of Tau Using Intra-assay Calibration StandardsApplication 61745177Pending
  • Gemcitabine ImmunoassayApplication PCTUS2012036723Pending
  • Clozapine ImmunoassayApplication PCTUS2012036257Pending
  • Vincristine ImmunoassayApplication PCTUS2011050773Pending
  • Irinotecan ImmunoassayApplication PCTUS2011028441Pending
  • Lenalidomide And Thalidomide ImmunoassaysApplication PCTUS2011025883Pending
  • Risperidone ImmunoassayApplication PCTUS2011025893Pending
  • Irinotecan ImmunoassayApplication PCTUS2010057264Pending
  • Imatinib ImmunoassayApplication PCTUS2010029566Pending
  • Stabilized Standards For Busulfan ImmunoassayApplication PCTUS2009054863Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .